Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (61-70 of 365) with videos related to

Pageof 37
Sort By:
BMC Infectious Diseases|October 16, 2015
A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic reviewLisa Lindsay, Joanne Wolter, Ilse De Coster, et al.
Statistics in Medicine|February 25, 2012
Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological dataNele Goeyvaerts, Niel Hens, Heidi Theeten, et al.
The Journal of Infectious Diseases|September 3, 2017
Effect of Prepregnancy Pertussis Vaccination in Young InfantsKirsten Maertens, Thao Mai Phuong Tran, Niel Hens, et al.
Mathematical Biosciences|January 29, 2009
Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicellaBenson Ogunjimi, Niel Hens, Nele Goeyvaerts, et al.
Vaccine|September 29, 2011
Burden and prevention of viral hepatitis in BulgariaDavid Fitzsimons, Mira Kojouharova, Johannes Hallauer, et al.
BMC Infectious Diseases|January 22, 2009
Mining social mixing patterns for infectious disease models based on a two-day population survey in BelgiumNiel Hens, Nele Goeyvaerts, Marc Aerts, et al.
Annals of Global Health|August 4, 2020
Point-of-Care Tests for Hepatitis B Are Associated with A Higher Linkage to Care and Lower Cost Compared to Venepuncture Sampling During Outreach Screenings in an Asian Migrant PopulationErwin Ho, Peter Michielsen, Pierre Van Damme, et al.
Vaccine|October 4, 2011
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?Joke Bilcke, Benson Ogunjimi, Frank Hulstaert, et al.
Human Vaccines & Immunotherapeutics|February 14, 2012
Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccineKoen Van Herck, Priya Diana Crasta, Marc Messier, et al.
Vaccine|February 11, 2014
Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adultsNiel Hens, Aklilu Habteab Ghebretinsae, Karin Hardt, et al.
Pageof 37

Showing results (61-70 of 365) with videos related to

Sort By:
Pageof 37
BMC Infectious Diseases|October 16, 2015
A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic reviewLisa Lindsay, Joanne Wolter, Ilse De Coster, et al.
Statistics in Medicine|February 25, 2012
Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological dataNele Goeyvaerts, Niel Hens, Heidi Theeten, et al.
The Journal of Infectious Diseases|September 3, 2017
Effect of Prepregnancy Pertussis Vaccination in Young InfantsKirsten Maertens, Thao Mai Phuong Tran, Niel Hens, et al.
Mathematical Biosciences|January 29, 2009
Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicellaBenson Ogunjimi, Niel Hens, Nele Goeyvaerts, et al.
Vaccine|September 29, 2011
Burden and prevention of viral hepatitis in BulgariaDavid Fitzsimons, Mira Kojouharova, Johannes Hallauer, et al.
BMC Infectious Diseases|January 22, 2009
Mining social mixing patterns for infectious disease models based on a two-day population survey in BelgiumNiel Hens, Nele Goeyvaerts, Marc Aerts, et al.
Annals of Global Health|August 4, 2020
Point-of-Care Tests for Hepatitis B Are Associated with A Higher Linkage to Care and Lower Cost Compared to Venepuncture Sampling During Outreach Screenings in an Asian Migrant PopulationErwin Ho, Peter Michielsen, Pierre Van Damme, et al.
Vaccine|October 4, 2011
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?Joke Bilcke, Benson Ogunjimi, Frank Hulstaert, et al.
Human Vaccines & Immunotherapeutics|February 14, 2012
Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccineKoen Van Herck, Priya Diana Crasta, Marc Messier, et al.
Vaccine|February 11, 2014
Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adultsNiel Hens, Aklilu Habteab Ghebretinsae, Karin Hardt, et al.
Pageof 37